Canada markets close in 3 hours 37 minutes

Oncolytics Biotech Inc. (ONC.TO)

Toronto - Toronto Real Time Price. Currency in CAD
Add to watchlist
1.5000+0.0300 (+2.04%)
As of 12:16PM EDT. Market open.
Currency in CAD

Valuation Measures4

Market Cap (intraday) 110.87M
Enterprise Value 76.38M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)4.02
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -2.29

Trading Information

Stock Price History

Beta (5Y Monthly) 1.46
52-Week Change 3-16.48%
S&P500 52-Week Change 322.64%
52 Week High 34.4900
52 Week Low 31.2000
50-Day Moving Average 31.4422
200-Day Moving Average 32.1934

Share Statistics

Avg Vol (3 month) 383.14k
Avg Vol (10 day) 344.57k
Shares Outstanding 575.42M
Implied Shares Outstanding 675.42M
Float 866.96M
% Held by Insiders 13.90%
% Held by Institutions 16.78%
Shares Short (Apr 15, 2024) 4305.71k
Short Ratio (Apr 15, 2024) 43.38
Short % of Float (Apr 15, 2024) 40.43%
Short % of Shares Outstanding (Apr 15, 2024) 40.41%
Shares Short (prior month Mar 15, 2024) 4312.64k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3May 25, 2018
Ex-Dividend Date 4N/A
Last Split Factor 2105:1000
Last Split Date 3May 25, 2018

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-55.47%
Return on Equity (ttm)-102.66%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -33.71M
Net Income Avi to Common (ttm)-27.75M
Diluted EPS (ttm)-0.4100
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)34.91M
Total Cash Per Share (mrq)0.46
Total Debt (mrq)423k
Total Debt/Equity (mrq)1.54%
Current Ratio (mrq)9.01
Book Value Per Share (mrq)0.37

Cash Flow Statement

Operating Cash Flow (ttm)-28.45M
Levered Free Cash Flow (ttm)-18M